BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 25951801)

  • 1. Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis.
    Schulte A; Pandeya N; Fawcett J; Fritschi L; Risch HA; Webb PM; Whiteman DC; Neale RE
    Cancer Causes Control; 2015 Jul; 26(7):1027-35. PubMed ID: 25951801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.
    Risch HA; Yu H; Lu L; Kidd MS
    J Natl Cancer Inst; 2010 Apr; 102(7):502-5. PubMed ID: 20181960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis.
    Trikudanathan G; Philip A; Dasanu CA; Baker WL
    JOP; 2011 Jan; 12(1):26-31. PubMed ID: 21206097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxin-Associated Gene A-Negative Strains of Helicobacter pylori as a Potential Risk Factor of Pancreatic Cancer: A Meta-Analysis Based on Nested Case-Control Studies.
    Chen XZ; Wang R; Chen HN; Hu JK
    Pancreas; 2015 Nov; 44(8):1340-4. PubMed ID: 26390415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma.
    Simán JH; Engstrand L; Berglund G; Forsgren A; Florén CH
    Scand J Gastroenterol; 2007 Aug; 42(8):933-40. PubMed ID: 17613922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori seropositivities and risk of pancreatic carcinoma.
    Risch HA; Lu L; Kidd MS; Wang J; Zhang W; Ni Q; Gao YT; Yu H
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):172-8. PubMed ID: 24234587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid diseases: a meta-analysis.
    Shi WJ; Liu W; Zhou XY; Ye F; Zhang GX
    Thyroid; 2013 Oct; 23(10):1294-300. PubMed ID: 23544831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori Seropositivity, ABO Blood Type, and Pancreatic Cancer Risk From 5 Prospective Cohorts.
    Lee AA; Wang QL; Kim J; Babic A; Zhang X; Perez K; Ng K; Nowak J; Rifai N; Sesso HD; Buring JE; Anderson GL; Wactawski-Wende J; Wallace R; Manson JE; Giovannucci EL; Stampfer MJ; Kraft P; Fuchs CS; Yuan C; Wolpin BM
    Clin Transl Gastroenterol; 2023 May; 14(5):e00573. PubMed ID: 36854058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity.
    Kamangar F; Dawsey SM; Blaser MJ; Perez-Perez GI; Pietinen P; Newschaffer CJ; Abnet CC; Albanes D; Virtamo J; Taylor PR
    J Natl Cancer Inst; 2006 Oct; 98(20):1445-52. PubMed ID: 17047193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori-CagA seropositivity and nitrite and ascorbic acid food intake as predictors for gastric cancer.
    López-Carrillo L; Torres-López J; Galván-Portillo M; Muñoz L; López-Cervantes M
    Eur J Cancer; 2004 Jul; 40(11):1752-9. PubMed ID: 15251166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is Helicobacter pylori seropositivity related to body mass index in the United States?
    Ioannou GN; Weiss NS; Kearney DJ
    Aliment Pharmacol Ther; 2005 Mar; 21(6):765-72. PubMed ID: 15771763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori, pepsinogen, and gastric adenocarcinoma in Hawaii.
    Nomura AM; Kolonel LN; Miki K; Stemmermann GN; Wilkens LR; Goodman MT; Perez-Perez GI; Blaser MJ
    J Infect Dis; 2005 Jun; 191(12):2075-81. PubMed ID: 15897993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori infection, chronic corpus atrophic gastritis and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort: A nested case-control study.
    Huang J; Zagai U; Hallmans G; Nyrén O; Engstrand L; Stolzenberg-Solomon R; Duell EJ; Overvad K; Katzke VA; Kaaks R; Jenab M; Park JY; Murillo R; Trichopoulou A; Lagiou P; Bamia C; Bradbury KE; Riboli E; Aune D; Tsilidis KK; Capellá G; Agudo A; Krogh V; Palli D; Panico S; Weiderpass E; Tjønneland A; Olsen A; Martínez B; Redondo-Sanchez D; Chirlaque MD; Hm Peeters P; Regnér S; Lindkvist B; Naccarati A; Ardanaz E; Larrañaga N; Boutron-Ruault MC; Rebours V; Barré A; Bueno-de-Mesquita HB; Ye W
    Int J Cancer; 2017 Apr; 140(8):1727-1735. PubMed ID: 28032715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Helicobacter pylori infection with esophageal adenocarcinoma and squamous cell carcinoma: a meta-analysis.
    Nie S; Chen T; Yang X; Huai P; Lu M
    Dis Esophagus; 2014; 27(7):645-53. PubMed ID: 24635571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the association between Helicobacter pylori and gastric cancer confined to CagA-positive strains?
    Held M; Engstrand L; Hansson LE; Bergström R; Wadström T; Nyrén O
    Helicobacter; 2004 Jun; 9(3):271-7. PubMed ID: 15165264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CagA-independent cluster of antigens related to the risk of noncardia gastric cancer: associations between Helicobacter pylori antibodies and gastric adenocarcinoma explored by multiplex serology.
    Song H; Michel A; Nyrén O; Ekström AM; Pawlita M; Ye W
    Int J Cancer; 2014 Jun; 134(12):2942-50. PubMed ID: 24259284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.
    Fernández de Larrea-Baz N; Pérez-Gómez B; Michel A; Romero B; Lope V; Pawlita M; Fernández-Villa T; Moreno V; Martín V; Willhauck-Fleckenstein M; López-Abente G; Castilla J; Fernández-Tardón G; Dierssen-Sotos T; Santibáñez M; Peiró R; Jiménez-Moleón JJ; Navarro C; Castaño-Vinyals G; Kogevinas M; Pollán M; de Sanjosé S; Del Campo R; Waterboer T; Aragonés N
    Cancer Epidemiol; 2017 Oct; 50(Pt A):76-84. PubMed ID: 28888185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus.
    Wu AH; Crabtree JE; Bernstein L; Hawtin P; Cockburn M; Tseng CC; Forman D
    Int J Cancer; 2003 Mar; 103(6):815-21. PubMed ID: 12516104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer.
    Stolzenberg-Solomon RZ; Blaser MJ; Limburg PJ; Perez-Perez G; Taylor PR; Virtamo J; Albanes D;
    J Natl Cancer Inst; 2001 Jun; 93(12):937-41. PubMed ID: 11416115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease.
    Tepler A; Narula N; Peek RM; Patel A; Edelson C; Colombel JF; Shah SC
    Aliment Pharmacol Ther; 2019 Jul; 50(2):121-131. PubMed ID: 31165513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.